2,3-Dinor-TXB2 (BioDeep_00000025024)

   

human metabolite Endogenous


代谢物信息卡片


(3Z)-5-[(2R,3S,4S)-4,6-dihydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]oxan-3-yl]pent-3-enoic acid

化学式: C18H30O6 (342.204228)
中文名称: 2,3-二正凝血噁烷 B2
谱图信息: 最多检出来源 Homo sapiens(urine) 85.71%

分子结构信息

SMILES: CCCCCC(C=CC1C(C(CC(O1)O)O)CC=CCC(=O)O)O
InChI: InChI=1S/C18H30O6/c1-2-3-4-7-13(19)10-11-16-14(8-5-6-9-17(21)22)15(20)12-18(23)24-16/h5-6,10-11,13-16,18-20,23H,2-4,7-9,12H2,1H3,(H,21,22)/b6-5-,11-10+/t13-,14-,15-,16+,18?/m0/s1

描述信息

Fatty Acyl-Eicosanoid - metabolite of thromboxane. Found to be excreted via urinary tract at a higher level in diabetic rats. A study demonstrates that thromboxane as well as prostacyclin biosynthesis is increased in 2 murine models of atherogenesis and is secondary to increased in vivo platelet activation. Assessment of their generation in these models may afford the basis for future studies on the functional role of these eicosanoids in the evolution and progression of atherosclerosisThromboxanes are eicosanoids. The eicosanoids consist of the prostaglandins (PGs), thromboxanes (TXs), leukotrienes (LTs), and lipoxins (LXs). The PGs and TXs are collectively identified as prostanoids. Prostaglandins were originally shown to be synthesized in the prostate gland, thromboxanes from platelets (thrombocytes), and leukotrienes from leukocytes, hence the derivation of their names. All mammalian cells except erythrocytes synthesize eicosanoids. These molecules are extremely potent, able to cause profound physiological effects at very dilute concentrations. All eicosanoids function locally at the site of synthesis, through receptor-mediated G-protein linked signalling pathways.
Fatty Acyl-Eicosanoid - metabolite of thromboxane. Found to be excreted via urinary tract at a higher level in diabetic rats. A study demonstrates that thromboxane as well as prostacyclin biosynthesis is increased in 2 murine models of atherogenesis and is secondary to increased in vivo platelet activation. Assessment of their generation in these models may afford the basis for future studies on the functional role of these eicosanoids in the evolution and progression of atherosclerosis

同义名列表

7 个代谢物同义名

(3Z)-5-[(2R,3S,4S)-4,6-dihydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]oxan-3-yl]pent-3-enoic acid; 2,3-Dinor-Thromboxane B2; 2,3-Dinor thromboxane B2; 2,3-Dinor-thromboxane; 2,3-Dinorthromboxane; 2,3-Dinor TXB2; 2,3-Dinor-TXB2



数据库引用编号

9 个数据库交叉引用编号

分类词条

相关代谢途径

Reactome(0)

BioCyc(0)

PlantCyc(0)

代谢反应

1 个相关的代谢反应过程信息。

Reactome(0)

BioCyc(0)

WikiPathways(1)

Plant Reactome(0)

INOH(0)

PlantCyc(0)

COVID-19 Disease Map(0)

PathBank(0)

PharmGKB(0)

1 个相关的物种来源信息

在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有:

  • PubMed: 来源于PubMed文献库中的文献信息,我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表,这个列表按照代谢物同时出现的文献数量降序排序,取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
  • NCBI Taxonomy: 通过文献数据挖掘,得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序,取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
  • Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
  • Chemical Reaction: 在化学反应过程中,存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。

点击图上的相关代谢物的名称,可以跳转到相关代谢物的信息页面。



文献列表

  • Crystal M Hoh, Stephanie A Smith, Maureen A McMichael, Julie K Byron. Evaluation of effects of low-dose aspirin administration on urinary thromboxane metabolites in healthy dogs. American journal of veterinary research. 2011 Aug; 72(8):1038-45. doi: 10.2460/ajvr.72.8.1038. [PMID: 21801060]
  • Gioacchino Calapai, Achille P Caputi, Carmen Mannucci, Giuseppina A Russo, Evan Gregg, Riccardo Puntoni, Frazer Lowe, Mike McEwan, Antonella Bassi, Stefania Morandi, Alfredo Nunziata. Cardiovascular biomarkers in groups of established smokers after a decade of smoking. Basic & clinical pharmacology & toxicology. 2009 Apr; 104(4):322-8. doi: 10.1111/j.1742-7843.2008.00361.x. [PMID: 19175368]
  • L Zhao, T Ding, T Cyrus, Y Cheng, H Tian, M Ma, R Falotico, D Praticò. Low-dose oral sirolimus reduces atherogenesis, vascular inflammation and modulates plaque composition in mice lacking the LDL receptor. British journal of pharmacology. 2009 Mar; 156(5):774-85. doi: 10.1111/j.1476-5381.2008.00080.x. [PMID: 19220291]
  • Frazer J Lowe, Evan O Gregg, Michael McEwan. Evaluation of biomarkers of exposure and potential harm in smokers, former smokers and never-smokers. Clinical chemistry and laboratory medicine. 2009; 47(3):311-20. doi: 10.1515/cclm.2009.069. [PMID: 19676143]
  • Jennifer C Sullivan, Jennifer M Sasser, David M Pollock, Jennifer S Pollock. Sexual dimorphism in renal production of prostanoids in spontaneously hypertensive rats. Hypertension (Dallas, Tex. : 1979). 2005 Mar; 45(3):406-11. doi: 10.1161/01.hyp.0000156879.83448.93. [PMID: 15699443]
  • Pertti Saloheimo, Seppo Juvela, Asko Riutta, Juhani Pyhtinen, Matti Hillbom. Thromboxane and prostacyclin biosynthesis in patients with acute spontaneous intracerebral hemorrhage. Thrombosis research. 2005; 115(5):367-73. doi: 10.1016/j.thromres.2004.08.026. [PMID: 15733969]
  • D O Stichtenoth, F J Kreutzer, F M Gutzki, D Tsikas, V Nowak, J C Frölich. Effects of intravenous oxygen on prostacyclin and thromboxane formation in patients with peripheral occlusive arterial disease. Prostaglandins, leukotrienes, and essential fatty acids. 2001 Oct; 65(4):211-4. doi: 10.1054/plef.2001.0313. [PMID: 11728174]
  • R Kaaja, V Pettilä, P Leinonen, O Ylikorkala. Increased thromboxane production in women with a history of venous thromboembolic event: effect of heparins. British journal of haematology. 2001 Sep; 114(3):655-9. doi: 10.1046/j.1365-2141.2001.03001.x. [PMID: 11552994]
  • E E Tuppo, L J Forman, B W Spur, R E Chan-Ting, A Chopra, T A Cavalieri. Sign of lipid peroxidation as measured in the urine of patients with probable Alzheimer's disease. Brain research bulletin. 2001 Mar; 54(5):565-8. doi: 10.1016/s0361-9230(01)00450-6. [PMID: 11397549]
  • D Praticò, C Tillmann, Z B Zhang, H Li, G A FitzGerald. Acceleration of atherogenesis by COX-1-dependent prostanoid formation in low density lipoprotein receptor knockout mice. Proceedings of the National Academy of Sciences of the United States of America. 2001 Mar; 98(6):3358-63. doi: 10.1073/pnas.061607398. [PMID: 11248083]
  • D Praticò, T Cyrus, H Li, G A FitzGerald. Endogenous biosynthesis of thromboxane and prostacyclin in 2 distinct murine models of atherosclerosis. Blood. 2000 Dec; 96(12):3823-6. doi: NULL. [PMID: 11090066]
  • F M Delemarre, C M Thomas, R J van den Berg, H W Jongsma, E A Steegers. Urinary prostaglandin excretion in pregnancy: the effect of dietary sodium restriction. Prostaglandins, leukotrienes, and essential fatty acids. 2000 Oct; 63(4):209-15. doi: 10.1054/plef.2000.0211. [PMID: 11049696]
  • D Tsikas, F M Gutzki, M Böhme, I Fuchs, J C Frölich. Solid- and liquid-phase extraction for the gas chromatographic-tandem mass spectrometric quantification of 2,3-dinor-thromboxane B2 and 2,3-dinor-6-oxo-prostaglandin F1 alpha in human urine. Journal of chromatography. A. 2000 Jul; 885(1-2):351-9. doi: 10.1016/s0021-9673(99)00967-x. [PMID: 10941682]
  • H Numminen, M Syrjälä, G Benthin, M Kaste, M Hillbom. The effect of acute ingestion of a large dose of alcohol on the hemostatic system and its circadian variation. Stroke. 2000 Jun; 31(6):1269-73. doi: 10.1161/01.str.31.6.1269. [PMID: 10835443]
  • B Hoch, M Bernhard. Reduced prostacyclin to thromboxane A2 ratio is correlated with central apneas in preterm infants. Prostaglandins & other lipid mediators. 1999 Nov; 58(5-6):285-90. doi: 10.1016/s0090-6980(99)00043-x. [PMID: 10593170]
  • R Freese, S Basu, M Mutanen. Green tea extract does not affect urinary markers of lipid peroxidation or thromboxane or nitric oxide synthesis during a high-linoleic acid diet in healthy females. Lipids. 1999; 34 Suppl(?):S317. doi: 10.1007/bf02562331. [PMID: 10419191]
  • A M Turpeinen, A M Pajari, R Freese, R Sauer, M Mutanen. Replacement of dietary saturated by unsaturated fatty acids: effects of platelet protein kinase C activity, urinary content of 2,3-dinor-TXB2 and in vitro platelet aggregation in healthy man. Thrombosis and haemostasis. 1998 Oct; 80(4):649-55. doi: NULL. [PMID: 9798986]
  • G Davì, D Ferro, S Basili, L Iuliano, C Camastra, C Giammarresi, S Santarone, B Rocca, R Landolfi, G Ciabattoni, C Cordova, F Violi. Increased thromboxane metabolites excretion in liver cirrhosis. Thrombosis and haemostasis. 1998 Apr; 79(4):747-51. doi: 10.1055/s-0037-1615058. [PMID: 9569186]
  • S M Bode-Böger, R H Böger, S Kienke, M Böhme, L Phivthong-ngam, D Tsikas, J C Frölich. Chronic dietary supplementation with L-arginine inhibits platelet aggregation and thromboxane A2 synthesis in hypercholesterolaemic rabbits in vivo. Cardiovascular research. 1998 Mar; 37(3):756-64. doi: 10.1016/s0008-6363(97)00295-2. [PMID: 9659460]
  • J M Moutquin, C Lindsay, N Arial, P De Grandpré, R C-Gaudreault, J C Forest, J Massé. Do prostacyclin and thromboxane contribute to the 'protective effect' of pregnancies with chronic hypertension? A preliminary prospective longitudinal study. American journal of obstetrics and gynecology. 1997 Dec; 177(6):1483-90. doi: 10.1016/s0002-9378(97)70095-4. [PMID: 9423755]
  • K Farker, H Schweer, R Vollandt, N Nassr, U Nagel, H W Seyberth, A Hoffmann, M Oettel. Measurements of urinary prostaglandins in young ovulatory women during the menstrual cycle and in postmenopausal women. Prostaglandins. 1997 Sep; 54(3):655-64. doi: 10.1016/s0090-6980(97)00131-7. [PMID: 9373880]
  • M Tulppala, M Marttunen, V Söderstrom-Anttila, T Foudila, K Ailus, T Palosuo, O Ylikorkala. Low-dose aspirin in prevention of miscarriage in women with unexplained or autoimmune related recurrent miscarriage: effect on prostacyclin and thromboxane A2 production. Human reproduction (Oxford, England). 1997 Jul; 12(7):1567-72. doi: 10.1093/humrep/12.7.1567. [PMID: 9262298]
  • D Henrion, E Dechaux, F J Dowell, J Maclour, J L Samuel, B I Lévy, J B Michel. Alteration of flow-induced dilatation in mesenteric resistance arteries of L-NAME treated rats and its partial association with induction of cyclo-oxygenase-2. British journal of pharmacology. 1997 May; 121(1):83-90. doi: 10.1038/sj.bjp.0701109. [PMID: 9146891]
  • R Bräutigam, C Bräutigam, R Lorenz, W O Richter, B Engelmann. Arachidonic acid of platelet phospholipids is decreased after extracorporeal removal of plasma low density lipoproteins in patients with familial hypercholesterolemia. Atherosclerosis. 1997 May; 131(1):97-106. doi: 10.1016/s0021-9150(97)06087-5. [PMID: 9180250]
  • P O Kimblad, K Gréen, T Sjöberg, S Steen. Prostanoid release after lung transplantation. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 1996 Oct; 15(10):999-1004. doi: NULL. [PMID: 8913917]
  • F L Fimognari, G Piccirillo, J Lama, P Paganica, G Monteleone, W Gianni, M Cacciafesta, V Marigliano. Associated daily biosynthesis of cortisol and thromboxane A2: a preliminary report. The Journal of laboratory and clinical medicine. 1996 Jul; 128(1):115-21. doi: 10.1016/s0022-2143(96)90120-1. [PMID: 8759943]
  • J Nowak, L Barregård, G Benthin, G Granung, A Wennmalm. Thromboxane metabolite excretion in patients with hand-arm vibration syndrome. Clinical physiology (Oxford, England). 1996 Jul; 16(4):361-7. doi: 10.1111/j.1475-097x.1996.tb00725.x. [PMID: 8842572]
  • G Laffi, S Cinotti, E Filimberti, G Ciabattoni, R Caporale, F Marra, L Melani, A Grossi, V Carloni, P Gentilini. Defective aggregation in cirrhosis is independent of in vivo platelet activation. Journal of hepatology. 1996 Apr; 24(4):436-43. doi: 10.1016/s0168-8278(96)80164-4. [PMID: 8738730]
  • P Pancera, E Arosio, P Minuz, F Pirante, M Ribul, A Lechi. Changes in peripheral hemodynamics and vasodilating prostaglandins after high-dose short-term ibuprofen in chronically treated hypertensive patients. Prostaglandins, leukotrienes, and essential fatty acids. 1996 Mar; 54(3):217-22. doi: 10.1016/s0952-3278(96)90020-4. [PMID: 8860111]
  • R M van der Weiden, F M Helmerhorst, M J Keirse. Prostanoid excretion before in vitro fertilization relates to the likelihood of pregnancy. Prostaglandins, leukotrienes, and essential fatty acids. 1995 Dec; 53(6):419-21. doi: 10.1016/0952-3278(95)90106-x. [PMID: 8821123]
  • R T Mathie, J S Fleming, S E Barrow, J V Arnold, J J Brannan, J M Becket, J M Ritter, K M Taylor. The haemodynamic effects of the thromboxane A2 receptor antagonist GR32191B during cardiopulmonary bypass in the dog. Perfusion. 1995 Nov; 10(6):403-13. doi: 10.1177/026765919501000604. [PMID: 8747897]
  • D O Stichtenoth, N Selve, D Tsikas, F M Gutzki, J C Frölich. Increased total body synthesis of prostacyclin in rats with adjuvant arthritis. Prostaglandins. 1995 Nov; 50(5-6):331-40. doi: 10.1016/0090-6980(95)00137-9. [PMID: 8838242]
  • I Rauramo, S Ilmonen, L Viinikka, O Ylikorkala. Prostacyclin and thromboxane in pregnant and nonpregnant women in response to exercise. Obstetrics and gynecology. 1995 Jun; 85(6):1027-30. doi: 10.1016/0029-7844(95)00048-v. [PMID: 7770249]
  • R H Böger, S M Bode-Böger, E P Schröder, D Tsikas, J C Frölich. Increased prostacyclin production during exercise in untrained and trained men: effect of low-dose aspirin. Journal of applied physiology (Bethesda, Md. : 1985). 1995 May; 78(5):1832-8. doi: 10.1152/jappl.1995.78.5.1832. [PMID: 7649919]
  • G Rasmanis, O Vesterqvist, K Gréen, P Henriksson. Implications of the prognostic importance of exercise-induced thromboxane formation in survivors of an acute myocardial infarction. Prostaglandins. 1995 Apr; 49(4):247-53. doi: 10.1016/0090-6980(95)00019-7. [PMID: 7667506]
  • M Kawamura, Y Harada, M Katori. Evaluation of plasma 11-dehydro-thromboxane B2 as an indicator for thromboxane A2 synthesis in vivo in laboratory animals. Thrombosis research. 1995 Mar; 77(5):465-74. doi: 10.1016/0049-3848(95)93882-z. [PMID: 7778061]
  • J Roselló-Catafau, G Hotter, D Closa, M A Ortiz, J M Pou-Torello, M Gimeno, G Bioque, E Gelpí. Liver lipoxygenase arachidonic acid metabolites in streptozotocin-induced diabetes in rats. Prostaglandins, leukotrienes, and essential fatty acids. 1994 Dec; 51(6):411-3. doi: 10.1016/0952-3278(94)90057-4. [PMID: 7708806]
  • R Landolfi, E De Candia, B Rocca, G Ciabattoni, A Antinori, R Masetti, C Patrono. Effects of unfractionated and low molecular weight heparins on platelet thromboxane biosynthesis 'in vivo'. Thrombosis and haemostasis. 1994 Dec; 72(6):942-6. doi: 10.1055/s-0038-1648988. [PMID: 7740468]
  • I Adatia, S E Barrow, P D Stratton, J M Ritter, S G Haworth. Effect of intracardiac repair on biosynthesis of thromboxane A2 and prostacyclin in children with a left to right shunt. British heart journal. 1994 Nov; 72(5):452-6. doi: 10.1136/hrt.72.5.452. [PMID: 7818962]
  • C Prakash, G J Nelson, M M Wu, P C Schmidt, M A Phillips, I A Blair. Decreased systemic thromboxane A2 biosynthesis in normal human subjects fed a salmon-rich diet. The American journal of clinical nutrition. 1994 Sep; 60(3):369-73. doi: 10.1093/ajcn/60.3.369. [PMID: 8074067]
  • J Kurantsin-Mills, B O Ibe, C L Natta, J U Raj, R S Siegel, L S Lessin. Elevated urinary levels of thromboxane and prostacyclin metabolities in sickle cell disease reflects activated platelets in the circulation. British journal of haematology. 1994 Jul; 87(3):580-5. doi: 10.1111/j.1365-2141.1994.tb08316.x. [PMID: 7993800]
  • J Neiman, J Nowak, G Benthin, H Numminen, M Hillbom. Increased urinary excretion of a major thromboxane metabolite in early alcohol withdrawal. Clinical physiology (Oxford, England). 1994 Jul; 14(4):405-9. doi: 10.1111/j.1475-097x.1994.tb00399.x. [PMID: 7955938]
  • B J O'Connor, S Uden, T J Carty, J D Eskra, P J Barnes, K F Chung. Inhibitory effect of UK,74505, a potent and specific oral platelet activating factor (PAF) receptor antagonist, on airway and systemic responses to inhaled PAF in humans. American journal of respiratory and critical care medicine. 1994 Jul; 150(1):35-40. doi: 10.1164/ajrccm.150.1.8025768. [PMID: 8025768]
  • C Chiabrando, M Corada, A Bachi, R Fanelli. Urinary excretion of 2,3-dinor-thromboxane B1, a major metabolite of thromboxane B2 in the rat. Prostaglandins. 1994 Jun; 47(6):409-22. doi: 10.1016/0090-6980(94)90042-6. [PMID: 7938613]
  • D R de Waart, G C Koomen, R J Wanders. Studies on the urinary excretion of thromboxane B2 in Zellweger patients and control subjects: evidence for a major role for peroxisomes in the beta-oxidative chain-shortening of thromboxane B2. Biochimica et biophysica acta. 1994 Apr; 1226(1):44-8. doi: 10.1016/0925-4439(94)90057-4. [PMID: 8155738]
  • P Tagari, D H Callaghan, C Black, J A Yerge. Measurement of canine urinary thromboxanes by GC-MS and HPLC-RIA. Prostaglandins. 1994 Apr; 47(4):293-306. doi: 10.1016/0090-6980(94)90024-8. [PMID: 8041872]
  • H Schweer, B Watzer, H W Seyberth. Determination of seven prostanoids in 1 ml of urine by gas chromatography-negative ion chemical ionization triple stage quadrupole mass spectrometry. Journal of chromatography. 1994 Feb; 652(2):221-7. doi: 10.1016/0378-4347(93)e0408-i. [PMID: 8006107]
  • M L Foegh, Y Zhao, L Madren, M Rolnick, T O Stair, K S Huang, P W Ramwell. Urinary thromboxane A2 metabolites in patients presenting in the emergency room with acute chest pain. Journal of internal medicine. 1994 Feb; 235(2):153-61. doi: 10.1111/j.1365-2796.1994.tb01049.x. [PMID: 8308478]
  • J Fauler, A Thon, D Tsikas, H von der Hardt, J C Frölich. Enhanced synthesis of cysteinyl leukotrienes in juvenile rheumatoid arthritis. Arthritis and rheumatism. 1994 Jan; 37(1):93-7. doi: 10.1002/art.1780370114. [PMID: 8129769]
  • S R Smith, V B Kubacki, A Rakhit, L L Martin, A V Schaffer, M K Jasani, D J Hefty, T Johnston, C Cannon, W M Bennett. Chronic thromboxane synthase inhibition with CGS 12970 in human cyclosporine nephrotoxicity. Transplantation. 1993 Dec; 56(6):1422-6. doi: 10.1097/00007890-199312000-00029. [PMID: 8279014]
  • R Djurup, C Chiabrando, A Jörres, R Fanelli, M Foegh, H U Soerensen, P N Joergensen. Rapid, direct enzyme immunoassay of 11-keto-thromboxane B2 in urine, validated by immunoaffinity/gas chromatography-mass spectrometry. Clinical chemistry. 1993 Dec; 39(12):2470-7. doi: 10.1093/clinchem/39.12.2470. [PMID: 8252718]
  • I Adatia, S E Barrow, P D Stratton, V M Miall-Allen, J M Ritter, S G Haworth. Thromboxane A2 and prostacyclin biosynthesis in children and adolescents with pulmonary vascular disease. Circulation. 1993 Nov; 88(5 Pt 1):2117-22. doi: 10.1161/01.cir.88.5.2117. [PMID: 8222105]
  • D Hofmann, C W Hamm, R L Lorenz, W Terres, P C Weber. Evidence for sustained platelet activation in patients with early postinfarction angina. Thrombosis research. 1993 Oct; 72(2):139-43. doi: 10.1016/0049-3848(93)90215-a. [PMID: 8303651]
  • R M Keimowitz, G Pulvermacher, G Mayo, D J Fitzgerald. Transdermal modification of platelet function. A dermal aspirin preparation selectively inhibits platelet cyclooxygenase and preserves prostacyclin biosynthesis. Circulation. 1993 Aug; 88(2):556-61. doi: 10.1161/01.cir.88.2.556. [PMID: 8339418]
  • C Lemne, S Volk-Jovinge, J Nilsson, O Vesterqvist, U De Faire. Plasma growth factor activity and cardiac wall thickness. Journal of internal medicine. 1993 Jul; 234(1):9-15. doi: 10.1111/j.1365-2796.1993.tb00698.x. [PMID: 8326295]
  • C Chiabrando, L Rivoltella, E Alberti, M Bonollo, R Djurup, R Fanelli. Urinary excretion and origin of 11-dehydro-2,3-dinor-thromboxane B2 in man. Prostaglandins. 1993 May; 45(5):401-11. doi: 10.1016/0090-6980(93)90117-p. [PMID: 8321910]
  • I A Blair, C Prakash, M A Phillips, R M Dougherty, J M Iacono. Dietary modification of omega 6 fatty acid intake and its effect on urinary eicosanoid excretion. The American journal of clinical nutrition. 1993 Feb; 57(2):154-60. doi: 10.1093/ajcn/57.2.154. [PMID: 8424383]
  • I Adatia, S E Barrow, P Stratton, J M Ritter, S G Haworth. Abnormalities in the biosynthesis of thromboxane A2 and prostacyclin in children with cyanotic congenital heart disease. British heart journal. 1993 Feb; 69(2):179-82. doi: 10.1136/hrt.69.2.179. [PMID: 8435245]
  • F A Van Assche, B Spitz, M Hanssens, C Van Geet, J Arnout, J Vermylen. Increased thromboxane formation in diabetic pregnancy as a possible contributor to preeclampsia. American journal of obstetrics and gynecology. 1993 Jan; 168(1 Pt 1):84-7. doi: 10.1016/s0002-9378(12)90890-x. [PMID: 8420355]
  • D Closa, J Rosello-Catafau, A Martrat, G Hotter, O Bulbena, L Fernandez-Cruz, E Gelpi. Changes of systemic prostacyclin and thromboxane A2 in sodium taurocholate- and cerulein-induced acute pancreatitis in rats. Digestive diseases and sciences. 1993 Jan; 38(1):33-8. doi: 10.1007/bf01296770. [PMID: 7678383]
  • A Jendryczko, J Tomala. An imbalance between the excretion of thromboxane and prostacyclin metabolites in women after the menopause. Zentralblatt fur Gynakologie. 1993; 115(4):163-6. doi: NULL. [PMID: 8503234]
  • A Dotevall, C Rångemark, E Eriksson, J Kutti, H Wadenvik, A Wennmalm. Cigarette smoking increases thromboxane A2 formation without affecting platelet survival in young healthy females. Thrombosis and haemostasis. 1992 Nov; 68(5):583-8. doi: . [PMID: 1455405]
  • C Rångemark, G Benthin, E F Granström, L Persson, S Winell, A Wennmalm. Tobacco use and urinary excretion of thromboxane A2 and prostacyclin metabolites in women stratified by age. Circulation. 1992 Nov; 86(5):1495-500. doi: 10.1161/01.cir.86.5.1495. [PMID: 1423963]
  • R Landolfi, G Ciabattoni, P Patrignani, M A Castellana, E Pogliani, B Bizzi, C Patrono. Increased thromboxane biosynthesis in patients with polycythemia vera: evidence for aspirin-suppressible platelet activation in vivo. Blood. 1992 Oct; 80(8):1965-71. doi: . [PMID: 1327286]
  • B W Christman, C D McPherson, J H Newman, G A King, G R Bernard, B M Groves, J E Loyd. An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension. The New England journal of medicine. 1992 Jul; 327(2):70-5. doi: 10.1056/nejm199207093270202. [PMID: 1603138]
  • A Leonhardt, C Busch, H Schweer, H W Seyberth. Reference intervals and developmental changes in urinary prostanoid excretion in healthy newborns, infants and children. Acta paediatrica (Oslo, Norway : 1992). 1992 Mar; 81(3):191-6. doi: 10.1111/j.1651-2227.1992.tb12202.x. [PMID: 1511190]
  • M Katori, M Kawamura, M Sawada. [11-Dehydro-TXB2 and 2,3-dinor-TXB2 as new parameters of TXA2 generation]. Nihon rinsho. Japanese journal of clinical medicine. 1992 Feb; 50(2):349-54. doi: NULL. [PMID: 1613989]
  • G Di Minno, M Margaglione, F Cirillo, E Grandone, G Davì, G Ciabattoni, I Catalano, P Strisciuglio, G Andria, A Coppola. In vivo platelet activation in homozygous cystathionine beta-synthase deficiency: a probucol-sensitive phenomenon. Transactions of the Association of American Physicians. 1992; 105(?):149-56. doi: NULL. [PMID: 1308991]
  • T Kurki, L Viinikka, O Ylikorkala. Urinary excretion of prostacyclin and thromboxane metabolites in threatened preterm labor: effect of indomethacin and nylidrin. American journal of obstetrics and gynecology. 1992 Jan; 166(1 Pt 1):150-4. doi: 10.1016/0002-9378(92)91851-z. [PMID: 1733190]
  • R Hui, M Robillard, J H Grose, M Lebel, P Falardeau. Arachidonic acid does not share the antihypertensive properties of linoleic acid and fish oil omega-3 fatty acids in a model of angiotensin II-induced hypertension in the rat. Clinical and investigative medicine. Medecine clinique et experimentale. 1991 Dec; 14(6):518-24. doi: NULL. [PMID: 1794205]
  • A M Aitokallio-Tallberg, J K Jung, S J Kim, L U Viinikka, R O Ylikorkala. Urinary excretion of degradation products of prostacyclin and thromboxane is increased in patients with gestational choriocarcinoma. Cancer research. 1991 Aug; 51(16):4146-8. doi: NULL. [PMID: 1868436]
  • S E Barrow, P D Stratton, N Benjamin, T Brassfield, J M Ritter. Reduction of LDL cholesterol by pravastatin does not influence platelet activation in patients with mild hypercholesterolaemia at risk of coronary heart disease. British journal of clinical pharmacology. 1991 Jul; 32(1):127-9. doi: 10.1111/j.1365-2125.1991.tb05625.x. [PMID: 1909541]
  • R F Spurney, R J Bernstein, P Ruiz, D S Pisetsky, T M Coffman. Physiologic role for enhanced renal thromboxane production in murine lupus nephritis. Prostaglandins. 1991 Jul; 42(1):15-28. doi: 10.1016/0090-6980(91)90090-3. [PMID: 1771236]
  • P S Ward, R W Fuller, J M Ritter, S J Cashman, A J Rees, C T Dollery. Excretion of metabolites of prostacyclin and thromboxane by rats with nephrotoxic nephritis: effects of interleukin-1. British journal of pharmacology. 1991 Jul; 103(3):1663-8. doi: 10.1111/j.1476-5381.1991.tb09844.x. [PMID: 1933130]
  • C Rångemark, A Wennmalm. Cigarette smoking and urinary excretion of markers for platelet/vessel wall interaction in healthy women. Clinical science (London, England : 1979). 1991 Jul; 81(1):11-5. doi: 10.1042/cs0810011. [PMID: 1649717]
  • A Morello, S Chang, A Jacob, S J Law, M Stastny, L Martin, A Pamidi, A Kotake. A chemiluminescent immunoassay for urinary thromboxane B2. Prostaglandins. 1991 Jul; 42(1):55-70. doi: 10.1016/0090-6980(91)90094-v. [PMID: 1771240]
  • A Wennmalm, G Benthin, E F Granström, L Persson, A S Petersson, S Winell. Relation between tobacco use and urinary excretion of thromboxane A2 and prostacyclin metabolites in young men. Circulation. 1991 May; 83(5):1698-704. doi: 10.1161/01.cir.83.5.1698. [PMID: 2022025]
  • M Tulppala, L Viinikka, O Ylikorkala. Thromboxane dominance and prostacyclin deficiency in habitual abortion. Lancet (London, England). 1991 Apr; 337(8746):879-81. doi: 10.1016/0140-6736(91)90205-4. [PMID: 1672969]
  • M Weinblatt, S Helfgott, J Coblyn, J Spragg, W M Uedelhoven, S Tumeh, R Sperling, R Lorenz, A Maier, P Weber. The effects of cyclosporin A on eicosanoid excretion in patients with rheumatoid arthritis. Arthritis and rheumatism. 1991 Apr; 34(4):481-5. doi: 10.1002/art.1780340413. [PMID: 2012627]
  • G Rasmanis, O Vesterqvist, K Gréen, O Edhag, P Henriksson. Prostacyclin production in myocardial infarction in the acute phase and during follow-up. Journal of internal medicine. 1991 Feb; 229(2):135-41. doi: 10.1111/j.1365-2796.1991.tb00321.x. [PMID: 1997639]
  • C Weber, M Höller, J Beetens, F De Clerck, F Tegtmeier. Determination of 6-keto-PGF1 alpha, 2,3-dinor-6-keto-PGF1 alpha, thromboxane B2, 2,3-dinor-thromboxane B2, PGE2, PGD2 and PGF2 alpha in human urine by gas chromatography-negative ion chemical ionization mass spectrometry. Journal of chromatography. 1991 Jan; 562(1-2):599-611. doi: . [PMID: 2026723]
  • A Wennmalm, G Benthin, K Caidahl, E F Granström, B Lanne, L Persson, A S Petersson, S Winell. Non-invasive assessment of the cardiovascular eicosanoids, thromboxane A2 and prostacyclin, in randomly sampled males, with special reference to the influence of inheritance and environmental factors. Clinical science (London, England : 1979). 1990 Dec; 79(6):639-45. doi: 10.1042/cs0790639. [PMID: 2176952]
  • NULL. Urinary thromboxane metabolites in pre-eclampsia. Lancet (London, England). 1990 May; 335(8698):1168-9. doi: 10.1016/0140-6736(90)91179-e. [PMID: 1971907]
  • B Tönshoff, R Momper, P G Kühl, H Schweer, K Schärer, H W Seyberth. Increased thromboxane biosynthesis in childhood hemolytic uremic syndrome. Kidney international. 1990 Apr; 37(4):1134-41. doi: 10.1038/ki.1990.96. [PMID: 2111418]
  • D J Fitzgerald, W Rocki, R Murray, G Mayo, G A FitzGerald. Thromboxane A2 synthesis in pregnancy-induced hypertension. Lancet (London, England). 1990 Mar; 335(8692):751-4. doi: 10.1016/0140-6736(90)90869-7. [PMID: 1969511]
  • S Katayama, M Inaba, Y Maruno, A Omoto, S Kawazu, J Ishii, M Sawada. Increased renal TXA2 synthesis in diabetes mellitus: simultaneous determination of urinary TXB2 and 2,3-dinor-TXB2. Prostaglandins, leukotrienes, and essential fatty acids. 1990 Jan; 39(1):47-51. doi: 10.1016/0952-3278(90)90171-g. [PMID: 2339136]
  • O Ylikorkala, E Hirvonen, A Saure, L Viinikka. Urinary excretion of prostacyclin and thromboxane metabolites in climacteric women: effect of estrogen-progestin replacement therapy. Prostaglandins. 1990 Jan; 39(1):33-7. doi: 10.1016/0090-6980(90)90092-a. [PMID: 2106714]
  • P Henriksson, G Rasmanis, O Edhag, O Vesterqvist, K Gréen. Thromboxane synthase inhibition: 'endoperoxide shunt phenomenon' does not occur in healthy humans in vivo. Prostaglandins. 1990 Jan; 39(1):99-107. doi: 10.1016/0090-6980(90)90098-g. [PMID: 2106716]
  • C Van Geet, J Arnout, E Eggermont, J Vermylen. Urinary thromboxane B2 and 2,3-dinor-thromboxane B2 in the neonate born at full-term age. Eicosanoids. 1990; 3(1):39-43. doi: NULL. [PMID: 2328133]
  • W M Uedelhoven, C O Meese, P C Weber. Analysis of the major urinary thromboxane metabolites, 2,3-dinorthromboxane B2 and 11-dehydrothromboxane B2, by gas chromatography-mass spectrometry and gas chromatography-tandem mass spectrometry. Journal of chromatography. 1989 Dec; 497(?):1-16. doi: 10.1016/0378-4347(89)80001-5. [PMID: 2625446]
  • R L Lorenz, W M Uedelhoven, S Fischer, A Ruetzel, P C Weber. A critical evaluation of urinary immunoreactive thromboxane: feasibility of its determination as a potential vascular risk indicator. Biochimica et biophysica acta. 1989 Dec; 993(2-3):259-65. doi: 10.1016/0304-4165(89)90174-8. [PMID: 2597697]
  • J M Ritter, J R Cockcroft, H S Doktor, J Beacham, S E Barrow. Differential effect of aspirin on thromboxane and prostaglandin biosynthesis in man. British journal of clinical pharmacology. 1989 Nov; 28(5):573-9. doi: 10.1111/j.1365-2125.1989.tb03544.x. [PMID: 2590611]
  • A Aitokallio-Tallberg, L Viinikka, O Ylikorkala. Urinary excretion of prostacyclin and thromboxane degradation products in patients with ovarian malignancy: effect of cytostatic treatment. British journal of cancer. 1989 Nov; 60(5):785-8. doi: 10.1038/bjc.1989.360. [PMID: 2803956]
  • C Chiabrando, V Pinciroli, A Campoleoni, A Benigni, A Piccinelli, R Fanelli. Quantitative profiling of 6-ketoprostaglandin F1 alpha, 2,3-dinor-6-ketoprostaglandin F1 alpha, thromboxane B2 and 2,3-dinor-thromboxane B2 in human and rat urine by immunoaffinity extraction with gas chromatography-mass spectrometry. Journal of chromatography. 1989 Oct; 495(?):1-11. doi: 10.1016/s0378-4347(00)82604-3. [PMID: 2613794]
  • M D Lupinetti, J R Sheller, F Catella, G A Fitzgerald. Thromboxane biosynthesis in allergen-induced bronchospasm. Evidence for platelet activation. The American review of respiratory disease. 1989 Oct; 140(4):932-5. doi: 10.1164/ajrccm/140.4.932. [PMID: 2508524]
  • P Patrignani, H Morton, M Cirino, A Lord, L Charette, J Gillard, J Rokach, C Patrono. Fractional conversion of thromboxane A2 and B2 to urinary 2,3-dinor-thromboxane B2 and 11-dehydrothromboxane B2 in the cynomolgus monkey. Biochimica et biophysica acta. 1989 Jul; 992(1):71-7. doi: 10.1016/0304-4165(89)90052-4. [PMID: 2752041]
  • P G Kühl, R B Cotton, H Schweer, H W Seyberth. Endogenous formation of prostanoids in neonates with persistent pulmonary hypertension. Archives of disease in childhood. 1989 Jul; 64(7 Spec No):949-52. doi: 10.1136/adc.64.7_spec_no.949. [PMID: 2673060]
  • D Rousson, M Guichardant, M Lagarde, J J Viala, M Dechavanne. Increased in vivo biosynthesis of prostacyclin and thromboxane A2 in chronic idiopathic thrombocytopenic purpura. British journal of haematology. 1989 Jul; 72(3):402-6. doi: 10.1111/j.1365-2141.1989.tb07723.x. [PMID: 2669929]
  • J Kabe. A double-blind placebo-controlled study of OKY-046 for the treatment of chronic asthma. Japanese journal of medicine. 1989 Jul; 28(4):552-5. doi: 10.2169/internalmedicine1962.28.552. [PMID: 2810931]